Medication info

Mineam Injection (Magnesium Sulfate Hydrate)

Prescription medicationIntramuscular injection · Intravenous injection
Ingredient · strength
Magnesium Sulfate Hydrate›0.1g / 1mL
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Colorless liquid in a colorless ampoule
Packaging
5 mL X 25 ampoules
Approval status
Active

MFDS item code 200805150 · Notified 2008.05.06

Summary

Main use
Electrolyte replenishment; prevention of convulsions (due to hypomagnesemia or eclampsia) and uterine rigidity
Who receives it
Adults · Children
Adult administration
○ Convulsions due to hypomagnesemia: Administer 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Administer 4 ∼ 5 g of this drug intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Administer an initial 4 g of this drug intravenously (16.2 mmol). An additional 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Administer 1 g of this drug intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this drug may be added to 5 % dextrose injection or 0.9 % sodium chloride injection and administered intravenously over 3 hours. During treatment of the deficiency, monitor the patient's renal excretory function closely.
Child administration
○ Children: The safety of this drug has not been studied.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Electrolyte replenishment; prevention of convulsions (due to hypomagnesemia or eclampsia) and uterine rigidity

  • Seizures due to hypomagnesemia
  • eclampsia seizures
  • uterine contractions
View approved original text

This medication is used to prevent and treat seizures caused by hypomagnesemia and eclampsia. It also helps prevent uterine contractions and is effective in replenishing electrolyte imbalances like hypomagnesemia. With these effects, it helps stabilize the patient's condition and improve symptoms.

How it is given

Adult administration

○ Convulsions due to hypomagnesemia: Administer 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Administer 4 ∼ 5 g of this drug intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Administer an initial 4 g of this drug intravenously (16.2 mmol). An additional 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Administer 1 g of this drug intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this drug may be added to 5 % dextrose injection or 0.9 % sodium chloride injection and administered intravenously over 3 hours. During treatment of the deficiency, monitor the patient's renal excretory function closely.

Child administration

○ Children: The safety of this drug has not been studied.

Precautions

This medication is provided in a glass ampoule, so care should be taken to avoid glass fragments when opening the container. Extra caution is needed when used on children or the elderly. This medication should not be used in patients with poor kidney function, unconscious patients, patients with elevated magnesium levels, patients with cardiac conduction disorders, or patients with myasthenia gravis. It should be administered with caution to children with intestinal parasitic infections or patients with heart disease. This medication may cause gastrointestinal symptoms such as vomiting or dry mouth, and rarely, cardiac arrhythmias or vasodilation. In cases of overdose, symptoms such as warmth, thirst, hypotension, central nervous system depression, bradycardia, and respiratory paralysis may occur, requiring immediate treatment. Caution should be exercised when this medication is used in conjunction with other sedatives or narcotic drugs, as it may enhance central nervous system depressant effects. Additionally, co-administration with iron preparations or certain antibiotics may reduce drug absorption, so consultation with a professional is advised. This medication may be used for pregnant women, especially those with eclampsia, for the safety of both fetus and mother, but it may affect the fetus with muscle relaxation or hypotension, necessitating close monitoring of fetal condition. It should be avoided during labor or postpartum due to the risk of respiratory depression in newborns. Safety during breastfeeding has not been established, so administration is not recommended unless in special cases. Elderly patients may have diminished body functions, so it is advised to slow the administration rate and adjust the dosage accordingly. Serious side effects may occur in cases of overdose, so if symptoms present, administration should be stopped immediately and antidotes should be used for treatment. This medication should be infused slowly at a concentration of less than 10%. It is also important not to mix with certain other medications as it may produce precipitates. To prevent infections, the injection site and instruments must be properly disinfected, used immediately after opening, and any leftover medication should not be reused.

Side effects

Vomiting, dry mouth, conduction disorder, bradycardia, flushing, peripheral vascular dilation, headache, dizziness, tremor, tingling, sensation of heat, thirst, hypotension, central nervous system suppression, heart rate suppression, respiratory paralysis, sensation of heat at the administration site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and ensure safe use.

Appearance and packaging

Appearance

Colorless liquid in a colorless ampoule

Package unit

5 mL X 25 ampoules

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.